A possible role for glutamate receptor-mediated excitotoxicity in chronic pain

Journal of Anesthesia

Volumn 15, Issue 1, 2001, Pages 39-48

  Petrenko, A B ^a   Shimoji, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

chronic pain; Excitoxicity; Glutamate receptors

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANALGESIA; ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; BRAIN CORTEX LESION; BRAIN NERVE CELL; BRAIN REGION; CHRONIC PAIN; CONTROL SYSTEM; CYTOTOXICITY; DISEASE COURSE; INTERNEURON; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NEUROPATHY; NOCICEPTION; NONHUMAN; PATHOLOGY; PERIPHERAL NERVE INJURY; PREDICTION; PREVENTION; REVIEW; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; SYNAPSE; THALAMUS; THEORY;

EID: 0035071664     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005400170050     Document Type: Review

References (105)

1. Pain mechanisms: A new theory
2. Central nervous system mechanisms of pain modulation
3. The dorsal horn: State-dependent sensory processing, plasticity and the generation of pain
4. Surgery in the rat during electrical analgesia by focal brain stimulation
5. Columnar organization in the mid-brain periaqueductal gray and the integration of emotional expression
6. Three bulbospinal pathways from the rostral medulla of the cat: An autoradiographic study of pain modulating systems
7. Physiological properties of stalked cells of the substantia gelatinosa intracellularly stained with horseradish peroxidase
8. Glutamatergic and GABAergic input to rat spinothalamic tract cells in the superficial dorsal horn
9. Neurochemistry and neural circuitry in the dorsal horn
10. Immunohistochemical localization of leucine-enkephalin in the spinal cord of the cat: Enkephalin-containing marginal neurons and pain modulation
11. Synaptic transmission and plasticity in the superficial dorsal horn
12. Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla
13. Spinal serotonin terminal system mediates antinociception
14. Postsynaptic inhibition of primate spinothalamic neurons by stimulation in nucleus raphe magnus
15. Serotonin innervation of physiologically identified lamina I projection neurons
16. Direct catecholaminergic innervation of primate spinothalamic tract neurons
17. Effects of iontophoresis of noradrenaline and stimulation of the periaqueductal gray on single-unit activity in the rat superficial dorsal horn
18. Raphe magnus stimulation-induced antinociception in the cat is associated with release of amino acids as well as serotonin in the lumbar dorsal horn
19. Spinal 5-HT3 receptor-mediated antinociception: Possible release of GABA
20. Inhibition by 5-hydroxytryptamine and noradrenaline in substantia gelatinosa of guinea-pig spinal trigeminal nucleus
21. Synaptic responses of substantia gelatinosa neurons to dorsal column stimulation in rat spinal cord in vitro
22. Primary afferent-evoked glycine-and GABA-mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro
23. Evidence for enkephalin immunoreactive neurons in the medulla oblongata projecting to the spinal cord
24. Time-related decreases in mu and delta opioid receptors in the superficial dorsal horn of the rat spinal cord following a large unilateral dorsal rhizotomy
25. Electrophysiology of opioids
26. Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat
27. Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord
28. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons
29. Midbrain periaqueductal gray (PAG) inhibits nociceptive inputs to sacral dorsal horn nociceptive neurons through alpha2-adrenergic receptors
30. Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin
31. mu-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat
32. Morphology and ultrastructure of physiologically identified substantia gelatinosa (lamina II) neurons with axons that terminate in deeper dorsal horn laminae (III-V)
33. Serotonin suppresses N-methyl-D-aspartate responses in acutely isolated spinal dorsal horn neurons of the rat
34. The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro
35. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats
36. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices
37. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration
38. 2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain
39. NMDA receptor-dependent long-term hyperalgesia after tail amputation in mice
40. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms
41. Selective modulation of NMDA responses by reduction and oxidation
42. Neuroprotective effects of glutamate antagonists and extracellular acidity
43. 2+ fluxes
44. Redox modulation of N-methyl-D-aspartate-stimulated neurotransmitter release from rat brain slices
45. The action of GGS-19755 on the redox enhancement of NMDA toxicity in rat cortical neurons in vitro
46. The modulation of N-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurons in vitro
47. Glycine potentiates strychnine-induced convulsions: Role of NMDA receptors
48. Redox manipulation of NMDA receptors in vivo: Alteration of acute pain transmission and dynorphin-induced allodynia
49. Subunit- and site-specific pharmacology of the NMDA receptor channel
50. The GluR2 hypothesis: Ca(+ +)-permeable AMPA receptors in delayed neurodegeneration
51. Upregulation of spinal glutamate receptors in chronic pain
52. 2+-permeable AMPA receptors
53. GluR1 and GluR2/3 subunits of the AMPA-type glutamate receptor are associated with particular types of neurone in laminae I-III of the spinal dorsal horn of the rat
54. 2+-permeable AMPA receptors
55. The distribution of neurons expressing calcium-permeable AMPA receptors in the superficial laminae of the spinal cord dorsal horn
56. Plasticity in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunits in the rat dorsal horn following deafferentation
57. 2+ concentration induced by acromelic acid in cultured rat spinal neurons
58. Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord
59. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells
60. Interactions between metabotropic and ionotropic glutamate receptor agonists in the rat spinal cord in vivo
61. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death
62. Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures
63. Metabotropic glutamate responses and the intracellular mechanisms
64. Behavioral and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord
65. Localization of glutamate receptors in dorsal horn of rat spinal cord
66. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn
67. Coexpression of multiple metabotropic glutamate receptors in axon terminals of single suprachiasmatic nucleus neurons
68. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders?
69. Excitatory amino acid receptors and neurodegeneration
70. Neurotransmitters in the regulation of neuronal cytoarchitecture
71. The vulnerability of spinal cord neurons to excitotoxic injury: Comparison with cortical neurons
72. 2+ entry into hippocampal neurons
73. + by monensin across bimolecular lipid membranes
74. Slow voltage-dependent changes in channel open-state probability underlie hysteresis of NMDA responses in Mg(2+)-free solutions
75. An integrated view of the molecular toxinology of sodium channel gating in excitable cells
76. Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists
77. Selective degeneration of inhibitory interneurons in the rat spinal cord induced by intrathecal infusion of acromelic acid
78. Kainate-induced apoptotic cell death in hippocampal neurons
79. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
80. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum
81. Does pain damage spinal cord neurons? Transsynaptic degeneration in rat following a surgical incision
82. Changes in spinal dorsal horn induced by peripheral nerve involvement
83. Adrenal medullary implants reduce transsynaptic degeneration in the spinal cord of rats following chronic constriction nerve injury
84. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: Effects of a chronic constriction injury, transection, and strychnine
85. Strychnine-enhanced transsynaptic degeneration of dorsal horn neurons in rats with an experimental painful neuropathy
86. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: An in vivo microdialysis study
87. Release and uptake of glutamate as related to excitotoxicity
88. Blind patch-clamp recordings from substantia gelatinosa neurons in adult rat spinal cord slices: Pharmacological properties of synaptic currents
89. NMDA and non-NMDA receptor mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization
90. Alteration of neuronal calcium homeostasis and excitotoxic vulnerability by chronic depolarization
91. Silent glutamatergic synapses and nociception in mammalian spinal cord
92. Activity-dependent neuronal plasticity following tissue injury and inflammation
93. The effects of peripheral nerve injury on dorsal root potentials and transmission of afferent signals into the spinal cord
94. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn
95. NMDA-receptor regulation of substance P release from primary afferent nociceptors
96. The effect of spinal GABA receptor agonists on tactile allodynia in a surgically induced neuropathic pain model in the rat
97. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists
98. Spinal cord interneuron degenerative atrophy caused by peripheral nerve lesions is prevented by serotonin depletion
99. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy
100. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts
101. Changes in GAD- and GABA-immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors
102. Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat
103. Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in the rat spinal cord that is prevented by peripheral neurectomy or neonatal capsaicin treatment
104. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence